Omzet 2024 * | 22,15 mln. 27,4 mln. 25,71 mln. | Omzet 2025 * | 36,37 mln. 44,98 mln. 42,21 mln. | Marktkapitalisatie | 850 mln. 1,05 mld. 987 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -42 mln. -51,95 mln. -48,75 mln. | Nettowinst (verlies) 2025 * | -72 mln. -89,06 mln. -83,57 mln. | EV/omzet 2024 * | 34,3 x |
Nettoliquiditeiten 2024 * | 91,29 mln. 113 mln. 106 mln. | Nettoliquiditeiten 2025 * | 82,95 mln. 103 mln. 96,28 mln. | EV/omzet 2025 * | 21,1 x |
K/w-verhouding 2024 * |
-48,4
x | K/w-verhouding 2025 * |
-34,8
x | Werknemers | 109 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 0% |
Recentste transcriptie over Silence Therapeutics plc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Craig Tooman
CEO | Chief Executive Officer | 58 | 06-01-21 |
Director of Finance/CFO | 52 | 01-04-21 | |
Curtis Rambaran
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Steven Romano
CTO | Chief Tech/Sci/R&D Officer | 64 | 29-07-19 |
David Lemus
BRD | Director/Board Member | 61 | 21-06-18 |
Iain Ross
CHM | Chairman | 71 | 02-07-04 |